Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
127182-44-9	Clarithromycin (9E)-O-Methyloxime CCC1C(C(C(C(=NOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	C₃₉H₇₂N₂O₁₃	777.0	≥90%	Click to inquire
127182-43-8	(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one CCC1C(C(C(C(=NO)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)NC)O)(C)OC)C)C)O)(C)O	C₃₇H₆₈N₂O₁₃	748.9	≥90%	Click to inquire
144604-03-5	Oxacyclotetradecane Erythromycin Derivative CCC1C(C=C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)(C)O	C₃₈H₆₇NO₁₂	729.9	≥90%	Click to inquire
167842-64-0	DE(8-carboxyoctyl)6-carboxyhexylmupirocin CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCC(=O)O)C)C(C)O	C₂₄H₄₀O₉	472.6	≥90%	Click to inquire
116182-44-6	Sodium;9-[(E)-4-[(2R,3S,4aS,7S,8S,8aR)-3,8-dihydroxy-2-[(2S,3S)-3-hydroxybutan-2-yl]-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyran-7-yl]-3-methylbut-2-enoyl]oxynonanoate CC(C1C(CC2COC(C(C2O1)O)CC(=CC(=O)OCCCCCCCCC(=O)[O-])C)O)C(C)O.[Na+]	C₂₆H₄₃NAO₉	522.6	≥90%	Click to inquire
1187586-61-3	(R,S)-Montelukast Bis-sulfide CC(C)(C1=CC=CC=C1CCC(C2=CC(=CC=C2)C(CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)SCC6(CC6)CC(=O)O)O	C₄₁H₄₆ClNO₅S₂	732.4	≥90%	Click to inquire
774538-96-4	Montelukast, cis- CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	C₃₅H₃₆ClNO₃S	586.2	≥90%	Click to inquire
105102-22-5	- -	-	-	HPLC≥98%	Click to inquire
28406-15-7	Pilocarpic acid CCC(C(CC1=CN=CN1C)CO)C(=O)O	C₁₁H₁₈N₂O₃	226.27	≥90%	Click to inquire
211738-08-8	2,2'-Bisnaloxone C=CCN1CCC23C4C(=O)CCC2(C1CC5=CC(=C(C(=C35)O4)O)C6=C(C7=C8C(=C6)CC9C1(C8(CCN9CC=C)C(O7)C(=O)CC1)O)O)O	C₃₈H₄₀N₂O₈	652.7	≥90%	Click to inquire

Clarithromycin (9E)-O-Methyloxime

Clarithromycin (9E)-O-Methyloxime

C₃₉H₇₂N₂O₁₃ 777.0

(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-14-ethyl-12,13-dihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one

克拉霉素杂质

C₃₇H₆₈N₂O₁₃ 748.9

Oxacyclotetradecane Erythromycin Derivative

(10E)-10,11-Didehydro-11-deoxy-6-O-methylerythromycin

C₃₈H₆₇NO₁₂ 729.9

DE(8-carboxyoctyl)6-carboxyhexylmupirocin

Pseudomonic Acid F

C₂₄H₄₀O₉ 472.6

Sodium;9-[(E)-4-[(2R,3S,4aS,7S,8S,8aR)-3,8-dihydroxy-2-[(2S,3S)-3-hydroxybutan-2-yl]-2,3,4,4a,5,7,8,8a-octahydropyrano[3,2-c]pyran-7-yl]-3-methylbut-2-enoyl]oxynonanoate

2H,5H-Pyrano[4,3-b]pyranyl Mupirocin Sodium Impurity

C₂₆H₄₃NAO₉ 522.6

(R,S)-Montelukast Bis-sulfide

孟鲁司特钠杂质D

C₄₁H₄₆ClNO₅S₂ 732.4

Montelukast, cis-

孟鲁司特钠顺式异构体

C₃₅H₃₆ClNO₃S 586.2

Pilocarpic acid

pilocarpic acid

C₁₁H₁₈N₂O₃ 226.27

2,2'-Bisnaloxone

纳洛酮二聚体杂质

C₃₈H₄₀N₂O₈ 652.7

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 832) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号